GAVI-documents

in page functions

27 June 2016

2015 FCE Mozambique brief

Findings from the 2015 Gavi Full Country Evaluations for Mozambique.

27 June 2016

2015 FCE Bangladesh brief

Findings from the 2015 Gavi Full Country Evaluations for Bangladesh.

27 June 2016

2015 FCE Uganda brief

Findings from the 2015 Gavi Full Country Evaluations for Uganda.

27 June 2016

2015 FCE Zambia brief

Findings from the 2015 Gavi Full Country Evaluations for Zambia.

16 June 2016

PCV Application guidelines transitioning countries

GUIDELINES FOR APPLICATIONS FOR ACCESS TO PNEUMOCOCCAL VACCINES FOR COUNTRIES THAT ARE IN ACCELERATED TRANSITION OR HAVE TRANSITIONED OUT OF GAVI SUPPORT.

24 May 2016

Guidelines on reporting and renewals in 2016 for all types of support

These guidelines provide guidance on the reporting process and requirements for all types of Gavi support. They also provide guidance on how a country requests renewal of support.

10 May 2016

Final evaluation of Gavi support to Albania

Final Evaluation of Gavi Support to Albania FINAL REPORT November 13, 2015 Akaki Zoidze Ketevan Goguadze Ivdity Chikovani Draft Report: Final Evaluation of GAVI Support to Albania ii Table of Content Acknowledgements .......................................................................................................

03 May 2016

2015 Full Country Evaluations report - Bangladesh

1 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in

03 May 2016

2015 Full Country Evaluations report - Cross country

0 1 Acknowledgments The Gavi FCE team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in stakeholder consult

03 May 2016

2015 Full Country Evaluations report - Mozambique

1 2 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved i

03 May 2016

2015 Full Country Evaluations report - Uganda

Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in st

03 May 2016

2015 Full Country Evaluations report - Zambia

1 Acknowledgments The Gavi Full Country Evaluations team would like to thank all immunization program partners (Ministries of Health, technical partners, Gavi Secretariat, and other stakeholders) in Bangladesh, Mozambique, Uganda, and Zambia, especially those individuals who participated in workshops, were involved in

03 May 2016

2015 FCE Cross country brief

Findings from the 2015 Gavi Full Country Evaluations CROSS-COUNTRY24, rue Salomon de Rothschild -92288 Suresnes -FRANCETl. : +33 (0)1 57 32 87 00 /Fax : +33 (0)1 57 32 87 87Web : www.carrenoir.comGAVIGAI_14_6999_LogoBlancQuad_GB30/07/2014QUIVALENCE QUADRICHROMIECYAN 40 % JAUNE 100 %CYAN 100 % MAGENTA 50 %CYAN 80 %Ce ch

18 April 2016

Summary HSS Evaluation Chad

Health System Strengthening Programme Evaluation Chad Gavi provided funding for Chad’s health system strengthening (HSS) programme from 2008-2012 but was extended beyond this period and no formal evaluation was conducted. The End of grant evaluation was requested by Gavi and the Ministry of Health (MSP) in Chad. Recogn

18 April 2016

Summary HSS Evaluation Cameroon

Health System Strengthening Programme Evaluation Cameroon Gavi provided funding for Cameroon’s health system strengthening (HSS) programme from 2007-2012 but the grant was extended and reprogramming of the HSS grant was done but no formal evaluation had been conducted. The 2015 HSS support evaluation was commissioned b

18 April 2016

Summary HSS Evaluation Afghanistan

Health System Strengthening Programme Evaluation Afghanistan Gavi provided funding for Afghanistan's health system strengthening (HSS) programme from 2008-2013. The 2013 HSS support evaluation was commissioned by the government of Afghanistan and conducted by Governance Institute-Afghanistan. Recognising that achieving

18 April 2016

Summary HSS Evaluation Yemen

Health System Strengthening Programme Evaluation Republic of Yemen Gavi provided funding for Yemen’s health system strengthening (HSS) programme from 2007-2013. The 2014 HSS support evaluation was commissioned by the government of Yemen and conducted by Sharon Beatty and Musaid Almagribi. BACKGROUND Recognising that ac

18 April 2016

Summary HSS Evaluation Tajikistan

Health System Strengthening Programme Evaluation Tajikistan Gavi provided funding for Tajikistan’s health system strengthening (HSS) programme from 2008-2014. The 2014 HSS support evaluation was commissioned by Gavi and conducted by Curatio International Foundation. BACKGROUND Recognising that achieving immunisation co

18 April 2016

Summary HSS Evaluation Sudan

Health System Strengthening Programme Evaluation Sudan Gavi provided funding for Sudan’s health system strengthening (HSS) programme from 2008-2013. The 2015 HSS support evaluation was commissioned by the Government of Sudan and conducted by Abebe Alebachew and Shahd Osman. BACKGROUND Recognising that achieving immunis

18 April 2016

Summary HSS Evaluation Nepal

Health System Strengthening Programme Evaluation Nepal Gavi provided funding for Nepal’s health system strengthening (HSS) programme through a pooled funding mechanism from 2010-2014. The 2015 HSS support evaluation was commissioned by Gavi and conducted by CEPA and HERD. BACKGROUND Recognising that achieving immunisat

18 April 2016

Summary HSS Evaluation Myanmar

Health System Strengthening Mid-term Programme Evaluation Myanmar Gavi provided funding for Myanmar’s health system strengthening (HSS) programme from 2012-2015. The 2013 mid-term evaluation of the HSS support programme was commissioned by the government of Myanmar and conducted by the Ministry of Health and the World

18 April 2016

Summary HSS Evaluation Madagascar

Health System Strengthening Programme Evaluation Madagascar Gavi provided funding for Madagascar’s health system strengthening (HSS) programme from 2008-2013. The 2014 HSS support evaluation was commissioned by Gavi and conducted by John Snow, Inc. BACKGROUND Recognising that achieving immunisation coverage is dependen

18 April 2016

Summary HSS Evaluation Ghana

Health System Strengthening Programme Evaluation Ghana Gavi provided funding for Ghana’s health system strengthening (HSS) programme from 2007-2013. The 2015 HSS support evaluation was commissioned by the government of Ghana and conducted by Tettey & Associates. BACKGROUND Recognising that achieving immunisation covera

18 April 2016

Summary HSS Evaluation Ethiopia

Health System Strengthening Programme Evaluation Ethiopia Gavi provided funding for Ethiopia’s health system strengthening (HSS) programme from 2006-2012. The 2014 HSS support evaluation was commissioned by Gavi and conducted by JaRco Consulting PLC. BACKGROUND Recognising that achieving immunisation coverage is depend

18 April 2016

Summary HSS Evaluation Eritrea

Health System Strengthening Programme Evaluation Eritrea Gavi provided funding for Eritrea’s health system strengthening (HSS) programme from 2010-2014. The 2015 HSS support evaluation was commissioned by the Government of Eritrea and conducted by ECOSOC. BACKGROUND Recognising that achieving immunisation coverage is d

18 April 2016

Summary HSS Evaluation Burkina Faso

Health System Strengthening Programme Evaluation Burkina Faso Gavi provided funding for Burkina Faso’s health system strengthening (HSS) programme from 2008-2012. The 2014 HSS support evaluation was commissioned by Gavi and conducted by SERSAP, USI, and CHUM. BACKGROUND Recognising that achieving immunisation coverage

18 April 2016

Summary HSS Evaluation Somalia

Health System Strengthening Programme Evaluation Somalia Gavi provided funding for Cameroon’s health system strengthening (HSS) programme from 2011-2015 but the grant was extended and reprogramming of the HSS grant was done but no formal evaluation had been conducted. The 2015 HSS support evaluation was commissioned by

18 April 2016

Tajikistan HSS Evaluation Report

Assessment of GAVI Support to Health System Strengthening in Tajikistan RFP No: AGSHST16062014 Final Report 16 September 2014Table of Contents Table of Contents .................................................................................................................................... 2 Acronyms ...............

18 April 2016

Nepal HSS Evaluation Report

GAVI ALLIANCE EVALUATION OF GAVI HEALTH SYSTEMS STRENGTHENING SUPPORT TO NEPAL THROUGH THE POOLED FUNDING MECHANISM 31ST MARCH 2015 FINAL REPORT Submitted by: Cambridge Economic Policy Associates Ltd In association with: Health Research and Social Development Forum CONTENTS Acronyms and abbreviations ..................

18 April 2016

Madagascar HSS Evaluation Report

Evaluation of the Gavi Health Systems Strengthening Support to Madagascar Evaluation Report 26 August 2015 John Snow, Inc. 1616 Fort Myer Drive, 16th Floor Arlington, VA 22209 USA Tel +1 703 528 7474 2 Table of Contents LIST OF TABLES AND FIGURES................................................................... 3 AC

18 April 2016

Ethiopia HSS Evaluation Report

Global Alliance for Vaccines and Immunisation, Health System Support, Ethiopia, 2006-2012 Final Evaluation GAVI Alliance JaRco Consulting PLC Addis Ababa, Ethiopia 30thSeptember 2014 2 3 List of Tables ....................................................................................................... 5 List of Figu

18 April 2016

Burkina Faso HSS Evaluation Report

EVALUATION REPORT BURKINA FASO MAY 2014 EVALUATION OF GAVI SUPPORT TO HEALTH SYSTEM STRENGTHENING IN BURKINA FASO Abel Bicaba Ludovic Queuille Slim Haddad Drissa Sia 2 SUMMARY MANDATEAND METHODS The mandate concerns the evaluation of GAVI support for health system strengthening in Burkina Faso focusing on the different

18 April 2016

Yemen HSS Evaluation Report

Final Evaluation of the GAVI Alliance Health System Strengthening Project (2007-2013) in the Republic of Yemen Final Report Sharon Beatty Musaid Almagribi April 14, 2014 1 Table of Contents Acknowledgements 2 List of Acronyms 3 Executive Summary 4 CHAPTER 1: BACKGROUND 6 I. Project description 6 II. Evaluation methodol

18 April 2016

Myanmar HSS Evaluation Report

PERFORMANCE ASSESSMENT OF GAVI-HSS INTERVENTIONS IN 20 TOWNSHIPS 2nd April 2014 Ministry of Health, World Health Organization, Country Office for Myanmar, International Health Policy Program, Thailand. Performance assessment of GAVI‐HSS interventions in 20 townships. Yangon, 2014. World Health Organization 2014 All ri

18 April 2016

Eritrea HSS Evaluation Report

1 Government of the State of Eritrea Ministry of Health GAVI HSS -END OF GRANT EVALUATION ECOSOC September 2015 i Acknowledgement The evaluation team would like to express its appreciation and sincere thanks to the Director General of the Policy, Planning and HRD -Dr. Andom Ugbamariam and his staff. Special thanks also

18 April 2016

Afghanistan HSS Evaluation Report

E v a l u a t i o n o f t h e G A V I A l l i a n c e F u n d e d H e a l t h S y s t e m S t r e n g t h e n i n g P r o g r a m 1 P a g e G o v e r n a n c e I n s t i t u t e -A f g h a n i s t a n ( G I -A ) COUNTRY EVALUATION REPORT EVALUATION OF THE GAVI ALLIANCE FUNDED HEALTH SYSTEM STRENGTHENING PROGRAM AFGHAN

18 April 2016

Chad HSS Evaluation Report

1 2 Contents ..................................................................................................................................................................... 1 Acknowledgments ...........................................................................................................................

18 April 2016

Ghana HSS Evaluation Report

GHS-GAVI Evaluation 2015 Page 0 GAVI HSS/ISS/CSO SUPPORT EVALUATION FINAL REPORT October, 2015 GHS-GAVI Evaluation 2015 Page 1 ACKNOWLEDGEMENTS The Evaluation Team (Tettey & Associates) gratefully acknowledges the support and role of various institutions, and individuals to the success of the assignment. We wish to exp

18 April 2016

Cameroon HSS Evaluation Report

Acknowledgment ....................................................................................................................................... 5 List of acronyms...................................................................................................................................... 7 Summary ......

18 April 2016

Gavi HSS meta-review report

GAVI, THE VACCINE ALLIANCE META-REVIEW OF COUNTRY EVALUATIONS OF GAVI’S HEALTH SYSTEM STRENGTHENING SUPPORT 18 MARCH 2016 FINAL REPORT Submitted by: Cambridge Economic Policy Associates Ltd CONTENTS Acronyms and abbreviations ..............................................................................................

18 April 2016

Somalia HSS Evaluation Report

EVALUATION OF THE GAVI, THE VACCINE ALLIANCE SUPPORT TO HEALTH SYSTEM STRENGTHENING IN SOMALIA Evaluation conducted by: SCHOOL OF HUMANITIES AND SOCIAL SCIENCES UNIVERSITY OF ZAMBIA LUSAKA ZAMBIA FEBRUARY 2016 Contact details: Room 133 HSS Building PO BOX 32379 Great east road Lusaka Zambia Tel. +260211290475 Email: ec

18 April 2016

Sudan HSS Evaluation Report

Evaluation of Gavi Health Systems Support 2008-2013 in Sudan Abebe Alebachew and Shahd Osman 20 October 2015 iv Contents Acronyms and Abbreviations ...................................................................................................... vi Map of Sudan .....................................................

04 April 2016

Product Switch Budget Template

Budget template for product and/or presentation switches for Gavi-supported vaccines. This document is intended to be used by countries applying for a Gavi product switch grant. [French] [Spanish] [Russian] 

04 April 2016

PCV 4-dose vials FAQs

Frequently asked questions on the 4-dose vials of pneumococcal conjugate vaccines. [French] [Spanish] [Russian] 

10 March 2016

Second annual Full Country Evaluations report (2014) – Gavi response

Second annual Full Country Evaluations report (2014) – Gavi response

26 February 2016

Pneumococcal AMC outcomes and impact evaluation - Summary

A summary of the Advance Market Commitment Pilot for Pneumococcal Vaccines: Outcomes and impact evaluation.

26 February 2016

Pneumococcal AMC impact evaluation Gavi management response

Gavi Secretariat management response to the outcomes and impact evaluation of the Pilot Advance Market Commitment for Pneumococcal Vaccines.

26 February 2016

Pneumococcal AMC outcomes and impact evaluation

The report assesses the extent to which the Advance Market Commitment (AMC) Pilot for Pneumococcal Vaccines has achieved its stated objectives and the overarching goal of reducing morbidity and mortality from pneumococcal disease. The evaluation also captures lessons learned.

25 February 2016

How to plan and conduct a joint appraisal

This guidance is intended for country stakeholders, alliance partners and Gavi Secretariat staff involved in planning and conducting the joint appraisal. This document explains the purpose and objectives of the joint appraisal and outlines suggested steps to organize a successful appraisal process.

25 February 2016

Frequently asked questions about the joint appraisal

Frequently asked questions about the joint appraisal.

25 February 2016

How to develop the joint appraisal report

This document accompanies the “Joint Appraisal Report Template” (Word file) and provides guidance to the joint appraisal team on how to develop the report. The content provided in each section of this document is intended to guide the appraisal discussions to ensure the relevant range of issues is covered in the appraisal and is sufficiently addressed in the final report.

01 January 2016

Guidance on financial reporting

Gavi Financial Management & Audit Requirements outline the principles and requirements for recipients of Gavi support applicable as of 1st January 2016. Accompanying these guidelines are a set of templates and examples for use.

18 December 2015

CCE Platform Application Instructions

Instructions for the CCE Optimisation Platform Application.

20 October 2015

Performance Framework Overview

An overview of the definition, content, use and introduction of the performance framework.

16 October 2015

MCV2 & MR guidelines

Specific guidelines on applications for measles second dose and measles-rubella vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

YF guidelines

Specific guidelines on applications for yellow fever vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

Pneumo FAQ

Frequently asked questions on support for pneumococcal conjugate vaccines.

16 October 2015

HSS guidelines

Support-specific guidelines for health system strengthening (HSS) support, which provide specific information on the type of support Gavi provides and any specific requirements and related guidance for developing an application.

16 October 2015

Pneumo guidelines

Specific guidelines on applications for pneumococcal conjugate vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

HSS application instructions

Presents detailed guidance on how to complete the HSS application form, and should be read prior and during completion of the form.

16 October 2015

General Guidelines

General Guidelines document for all types of Gavi support, which provides an introduction to Gavi and the types of support provided, information on country eligibility for accessing support, the application process and grant cycle as a whole as well as Gavi’s overarching approach/ requirements for country support.

16 October 2015

JE guidelines

Specific guidelines on applications for Japanese encephalitis vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

HPV FAQ

Frequently asked questions on support for human papillomavirus (HPV) vaccines.

16 October 2015

Rotavirus guidelines

Specific guidelines on applications for rotavirus vaccines under Gavi’s new and underused vaccine support (NVS).

16 October 2015

Rotavirus FAQ

Frequently asked questions on support for rotavirus vaccines.

16 October 2015

MenA guidelines

Specific guidelines on applications meningococcal A conjugate vaccines under Gavi’s new and underused vaccine (NVS) Support.

16 October 2015

HSS FAQ

Frequently asked questions on support for health system strengthening support.

16 October 2015

NVS application instructions

Presents detailed guidance on how to complete the NVS application form, and should be read prior and during completion of the form.

16 October 2015

HPV demo guidelines

Specific guidelines on applications for HPV vaccine demonstration programmes under Gavi’s new and underused vaccine support (NVS).

16 October 2015

YF FAQ

Frequently asked questions on support for yellow fever vaccines.

16 October 2015

JE FAQ

Frequently Asked Questions on support for Japanese encephalitis (JE) vaccines.

16 October 2015

MenA FAQ

Frequently asked questions on support for meningococcal A conjugate vaccines.

16 October 2015

HPV national guidelines

Specific guidelines on applications for human papillomavirus (HPV) vaccines for national introduction under Gavi’s new and underused vaccine support (NVS).

16 October 2015

IRC Review Criteria for 2016

The criteria used by the Independent Review Committee (IRC) to assess applications.

16 October 2015

MCV2 & MR FAQ

Frequently asked questions on support for measles second dose and measles-rubella vaccines.

15 October 2015

Guidelines - Exceptional opportunity to apply for HPV vaccine support

In June 2015 the Gavi Board decided to grant a subset of countries the one-time opportunity to apply for catalytic support for HPV vaccine introduction to countries that have not had the opportunity to apply due to the recent addition of this vaccine to the Gavi portfolio. These guidelines provide all necessary information to apply for this exceptional support.

15 October 2015

Guidelines - Exceptional opportunity to apply for MR vaccine support

In June 2015 the Gavi Board decided to grant a subset of countries the one-time opportunity to apply for catalytic support for MR vaccine introduction to countries that have not had the opportunity to apply due to the recent addition of this vaccine to the Gavi portfolio. These guidelines provide all necessary information to apply for this exceptional support.

15 October 2015

Guidelines - Exceptional opportunity to apply for JE vaccine support

In June 2015 the Gavi Board decided to grant a subset of countries the one-time opportunity to apply for catalytic support for JE vaccine introduction to countries that have not had the opportunity to apply due to the recent addition of this vaccine to the Gavi portfolio. These guidelines provide all necessary information to apply for this exceptional support.

09 September 2015

Guidance on evaluation of HSS grants

Information on independent evaluations of Gavi HSS grants.

09 September 2015

2015-2016 Gavi HSS Country Ceilings

Gavi’s total funding envelope for each country.

09 September 2015

Co-financing default

Information on what happens when a country does not fulfil its co-financing requirement on time.

09 September 2015

Guidance on grant modification for fragile countries

Information on when countries in emergency situations or with exceptional challenges may be eligible for additional flexibilities under the Fragility and Immunisation Policy.

09 September 2015

Guidance for developing vaccine introduction plans

Guidance on completing new vaccine introduction operational plans and a Plan of Action.

09 September 2015

Guidance on investments with high impact potential

Information on bottlenecks and associated activities that have been determined to have a high potential impact on immunisation outcomes.

09 September 2015

HPV resources

Links to useful resources for more information on the HPV vaccine.

21 August 2015

FAQ - Civil Society Access to GAVI Pricing for Vaccines

1 Civil society access to GAVI pricing for vaccines Frequently asked questions September 2013 1. Does GAVI support the delivery of immunisation services by civil society organisations? GAVI recognises the key role that civil society organisations (CSOs) play in the national immunisation programmes of many countries. 2.

03 August 2015

Gavi's grant application, monitoring and review redesign

Overview of how Gavi is enhancing its routine grant monitoring and reporting.

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Uganda

This brief presents findings for Uganda from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 July 2015

Lessons Learned from the 2014 Gavi Full Country Evaluations - HPV vaccine

This brief presents lessons learned from human papillomavirus (HPV) vaccine demonstration in Mozambique and preparation for HPV national introduction in Uganda during the 2014 period of the Gavi Full Country Evaluations (FCE).

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Bangladesh

This brief presents findings for Bangladesh from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Mozambique

This brief presents findings for Mozambique from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

20 July 2015

Gavi Full Country Evaluation 2014 Annual Dissemination Report

This report presents findings from the 2014 Gavi Full Country Evaluations (FCE).

20 July 2015

Findings from the 2014 Gavi Full Country Evaluation - Zambia

This brief presents findings for Zambia from the 2014 Gavi Full Country Evaluation (FCE) Annual Dissemination Report.

30 June 2015

FAQ - Grant management change process

The Gavi Alliance grant management change process Frequently asked questions May 2015 Overall change process 1. How was it decided that grant management changes were needed? Over recent years, through a series of consultation sessions, the Gavi Alliance Board, Programme and Policy Committee (PPC), partners, countries,

20 January 2015

Final evaluation of GAVI Alliance support to Bosnia and Herzegovina: Management Response

The Vaccine Alliance’s responses to key recommendations are outlined in the accompanying Management Action Plan.

15 January 2015

Final evaluation of GAVI Alliance support to Bosnia and Herzegovina

This report presents the lessons learnt and recommendations from an evaluation of Gavi’s support to Bosnia and Herzegovina and its transition after funding ended. The evaluation was conducted by the Curatio International Foundation in 2014.

15 January 2015

EAC assessment of the Evaluation of the GAVI Alliance Co-financing Policy

Gavi, the Vaccine Alliance Board Evaluation Advisory Committee (EAC) assessment of the quality and usefulness of the Norwegian Institute of Public Health’s "Evaluation of the Gavi Alliance Co-‐financing Policy".

22 December 2014

Gavi and Ebola - FAQ

Gavi and Ebola - Frequently asked questions.

18 August 2014

GAVI HSS Grant Categorisation 2014

This table is intended to provide ideas of HSS activities to applicants and to allow GAVI to analyse its HSS support by type of grants.

03 July 2014

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response.

 



close icon

modal window here